Manufacturers Life Insurance Company, The Graphite Bio, Inc. Transaction History

Manufacturers Life Insurance Company, The

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $26,946 - $65,856	-12,592 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$5.1 - $13.06 $64,219 - $164,451	12,592 New	12,592 $64,000
Q1 2022 May 20, 2022	BUY	$5.1 - $13.06 $64,219 - $164,451	12,592 New	12,592 $64,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.